Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 124,561 |
|
|||||
| News | - | ||||||
| Day High | 18.685 | Low High |
|||||
| Day Low | 18.38 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Myriad Genetics Inc | MYGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.02 | -0.11% | 18.49 | 12:35:50 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 18.47 | 18.38 | 18.685 | 18.51 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,595 | 124,561 | $ 18.46 | $ 2,299,974 | - | 13.82 - 24.21 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:38:31 | 11 | $ 18.50 | USD |
Myriad Genetics (MYGN) Options Flow Summary
Myriad Genetics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.66B | 89.87M | - | 753.2M | -263.3M | -2.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Myriad Genetics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MYGN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 20.34 | 20.48 | 18.21 | 18.98 | 600,380 | -1.85 | -9.10% |
| 1 Month | 22.33 | 22.485 | 18.21 | 20.34 | 547,445 | -3.84 | -17.20% |
| 3 Months | 22.43 | 23.75 | 18.21 | 21.62 | 626,417 | -3.94 | -17.57% |
| 6 Months | 15.07 | 23.75 | 13.82 | 19.80 | 668,442 | 3.42 | 22.69% |
| 1 Year | 21.55 | 24.21 | 13.82 | 19.73 | 596,992 | -3.06 | -14.20% |
| 3 Years | 27.13 | 36.9547 | 13.82 | 22.72 | 577,503 | -8.64 | -31.85% |
| 5 Years | 31.98 | 48.40 | 9.24 | 22.46 | 733,405 | -13.49 | -42.18% |
Myriad Genetics Description
| Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 35-gene panel with the capability to identify the elevated risk of developing eight types of cancer. Other diagnostic products include BRACAnalysisCDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; Prequel, with is a noninvasive prenatal test; and Prolaris, which identifies prostate cancer patients that can pursue active surveillance. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies. |
